VUB's Revolutionary Radar Technology Seeks Partners Tuesday 02/09/2025 VUB researchers worked on a revolutionary tool for the construction and inspection industry. This technology offers a non-invasive way to get a clear picture of what's hidden inside walls. How Cocoa Variety and Yeasts Determine Chocolate Flavour Thursday 28/08/2025 VUB research reveals how the type of cocoa bean and the yeasts involved in fermentation have a significant impact on the ultimate flavour of chocolate. Belgium Celebrates 100,000 Public Charging Points Friday 22/08/2025 Belgium reached the milestone of 100,000 public charging points. The achievement was celebrated at a symbolic event co-hosted by the VUB MOBI Electromobility Research Centre and EV Belgium. Get to know Maarten De Ruyck Friday 22/08/2025 Meet Maarten, Program Manager of StartLab.Brussels for Academics. In his role, he is on a mission to connect VUB researchers with the guidance of the StartLab.Brussels entrepreneurship program, helping them transform their ideas into real-world innovations. ORION Friday 22/08/2025 The ERIS team proudly announces that the ORION consortium has received an EU grant. Prof. Vagelis Papakonstantinou, from the Law, Science, Technology and Society Research Group of VUB, will coordinate this project for VUB. SALVUS Thursday 21/08/2025 The ERIS team proudly announces that the SALVUS consortium has received an EU grant. Prof. Rosamunde Van Brakel, from the Law, Science, Technology and Society Research Group of VUB, will coordinate this project for VUB. Luceda Photonics joins forces with Semitronix to accelerate photonics innovation Tuesday 12/08/2025 Luceda Photonics announced its acquisition by SMTX Technologies Singapore Pte. Ltd., part of Semitronix Group. This strategic partnership combines Luceda’s expertise in photonic integrated circuit (PIC) design software with Semitronix’s advanced semiconductor solutions. Precirix Receives FDA Green Light for Novel Cancer Therapy Monday 28/07/2025 VUB spin-off Precirix announced that the U.S. Food and Drug Administration (FDA) has accepted its Investigational New Drug (IND) application for CAM-FAP-Ac-225. This significant achievement paves the way for Precirix to begin a Phase 1 clinical trial for patients battling FAP-positive tumors. ERIS Thursday 03/07/2025 The ERIS team proudly announces that the ERIS consortium has received an EU grant. Prof. dr. De Asmundis, programme director of the postgraduate Training in Cardiac Electrophysiology & Pacing, will coordinate this project for VUB. Swave Photonics raises €6M for holographic display technology Thursday 03/07/2025 Swave Photonics, a spin-off from imec and VUB, has raised an additional €6 million in Series A funding. This follow-on investment will accelerate the development of Swave's innovative holographic display technology for Spatial + AI Computing. Animab secures €10M for antibiotic-free animal health solution Tuesday 01/07/2025 Animab, a VUB-VIB-UGent spin-off, has secured €10 million in Series B funding to launch its innovative antibiotic-free solution for piglet health, tackling antimicrobial resistance. Annual Report 2024 of the Vice-rectorate Innovation & Industry Relations Wednesday 25/06/2025 Discover the real-world impact of VUB's innovative research in 2024 with our newly released Annual Report 2024. From new spin-offs to impactful industry collaborations, check out the full report for all the details. Pages « First ‹ Previous 1 2 3 4 (current) 5 6 7 8 9 … Next › Last »
